NCT05773131

Brief Summary

Collaboration between family members and mechanically ventilated (MV) patients in the intensive care unit (ICU) is essential for improving patients' hospitalization experiences and outcomes. However, numerous hospitals have reduced the visiting time and frequency in ICUs due to the global spread of SARS-CoV-2 in recent years, aggravating mental problems and reducing the satisfaction of ICU patients and their families. Therefore, we propose an effective intervention strategy to enhance patient-family bonding and improve patient mental health and ICU experience by constructing a remote cross-platform virtual reality collaboration system (VRCS) for connecting family members at home with patients in the ICU. We aim to assess the effects of VRCS on the mental health of ICU patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
566

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

March 7, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 17, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 17, 2024

Completed
Last Updated

March 17, 2023

Status Verified

June 1, 2022

Enrollment Period

1 year

First QC Date

March 6, 2023

Last Update Submit

March 6, 2023

Conditions

Keywords

ICUmechanically ventilated patientsvirtual realitymental healthsocial connection

Outcome Measures

Primary Outcomes (1)

  • Hospital Anxiety and Depression Scale

    The HADS is designed by Zigmond and Snaith in 1983 to assess anxiety and depression symptoms in medical patients, including 14 items and every item scoring from 1 to 4. It includes two scales, one for anxiety (HADS-A) and another for depression (HADS-D). Each scale has 7 items and has a total score range from 7 to 28. The diagnostic criteria are that if the diagnosed person scores more than 11 points on any scale, it can be regarded as a confirmed case.

    1 year

Secondary Outcomes (13)

  • Blood pressure

    1 year

  • Heart Rate

    1 year

  • Respiratory rate

    1 year

  • Oxygen saturation level

    1 year

  • Activation of cranial nerve signals

    1 year

  • +8 more secondary outcomes

Study Arms (2)

VR collaborative visualization group

EXPERIMENTAL

In this intervention system, the stimulation materials, communication interface, collaboration tasks, and immersive 360-degree scenario will be played inside a commercially available head-mounted display on the patient side, as well as these materials will be played in the smartphone on the family members' side.

Device: VR collaborative visualization system

Standard ICU Care

NO INTERVENTION

Patients will be treated with standard ICU care and not receive VR stimulation.

Interventions

Patients wear virtual reality head-mounted displays while family members using smart phones to interact in a same virtual space.

VR collaborative visualization group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mechanical ventilation time \> 24h, and is currently undergoing mechanical ventilation;
  • Age ≥ 18 years old, no upper age limit;
  • Language: Chinese;
  • RAAS score ≥ -2 points;
  • Hemodynamic stability.

You may not qualify if:

  • Severe visual impairment (WHO classification: severe visual impairment) or hearing impairment (WHO classification: severe hearing loss);
  • Cognitive and consciousness impairment;
  • Head trauma or surgery resulting in an inability to wear HMDs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PUMC

Beijing, Beijing Municipality, 100730, China

RECRUITING

MeSH Terms

Conditions

Psychological Well-Being

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Study Officials

  • Yun Long, MD

    Peking Union Medical College

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2023

First Posted

March 17, 2023

Study Start

March 7, 2023

Primary Completion

March 17, 2024

Study Completion

March 17, 2024

Last Updated

March 17, 2023

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations